Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.

Program will expand access in certain regions where Revuforj is not available commercially, as permitted by local regulations -- Program will ...